Cargando…

Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: technical aspects studied in a large animal model

OBJECTIVE: To assess the accuracy of a scout dose of holmium-166 poly(L-lactic acid) microspheres ((166)Ho-PLLA-MS) in predicting the distribution of a treatment dose of (166)Ho-PLLA-MS, using single photon emission tomography (SPECT). METHODS: A scout dose (60 mg) was injected into the hepatic arte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vente, M. A. D., de Wit, T. C., van den Bosch, M. A. A. J., Bult, W., Seevinck, P. R., Zonnenberg, B. A., de Jong, H. W. A. M., Krijger, G. C., Bakker, C. J. G., van het Schip, A. D., Nijsen, J. F. W.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Experimental
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835632/ https://www.ncbi.nlm.nih.gov/pubmed/19789880 http://dx.doi.org/10.1007/s00330-009-1613-1

Ejemplares similares

MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation
por: van de Maat, Gerrit H., et al.
Publicado: (2012)

Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(l-lactic acid) microspheres in healthy pigs
por: Vente, M. A. D., et al.
Publicado: (2008)

Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radioembolization: a validation study
por: Vente, M. A. D., et al.
Publicado: (2009)

Intratumoral Administration of Holmium-166 Acetylacetonate Microspheres: Antitumor Efficacy and Feasibility of Multimodality Imaging in Renal Cancer
por: Bult, Wouter, et al.
Publicado: (2013)

Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial
por: Smits, Maarten LJ, et al.
Publicado: (2010)

Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study
por: Braat, Arthur J. A. T., et al.
Publicado: (2017)

Radioactive Holmium Acetylacetonate Microspheres for Interstitial Microbrachytherapy: An In Vitro and In Vivo Stability Study
por: Bult, Wouter, et al.
Publicado: (2011)

Holmium Nanoparticles: Preparation and In Vitro Characterization of a New Device for Radioablation of Solid Malignancies
por: Bult, Wouter, et al.
Publicado: (2010)

Intratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinoma: preliminary results of first use
por: Bakker, Robbert C., et al.
Publicado: (2018)

Development of an MRI-Guided Approach to Selective Internal Radiation Therapy Using Holmium-166 Microspheres
por: Roosen, Joey, et al.
Publicado: (2021)

Intratumoral injection of holmium-166 microspheres as neoadjuvant therapy of soft tissue sarcomas in dogs
por: Morsink, Nino Chiron, et al.
Publicado: (2022)

Feasibility of CT quantification of intratumoural (166)Ho-microspheres
por: C. Bakker, R., et al.
Publicado: (2020)

Case Report: Radioactive Holmium-166 Microspheres for the Intratumoral Treatment of a Canine Pituitary Tumor
por: Morsink, Nino Chiron, et al.
Publicado: (2021)

The various therapeutic applications of the medical isotope holmium-166: a narrative review
por: Klaassen, Nienke J. M., et al.
Publicado: (2019)

Holmium-166 Radioembolization: Current Status and Future Prospective
por: Stella, Martina, et al.
Publicado: (2022)

(166)Holmium–(99)(m)Technetium dual-isotope imaging: scatter compensation and automatic healthy-liver segmentation for (166)Holmium radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2022)

Trans-arterial hepatic radioembolisation of yttrium-90 microspheres
por: Murthy, R, et al.
Publicado: (2006)

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2023)

Gamma camera characterization at high holmium-166 activity in liver radioembolization
por: Stella, Martina, et al.
Publicado: (2021)

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol
por: Andel, Daan, et al.
Publicado: (2023)

Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery
por: Roosen, Joey, et al.
Publicado: (2022)

Quality of life in patients with liver tumors treated with holmium-166 radioembolization
por: van Roekel, Caren, et al.
Publicado: (2019)

Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial
por: van den Hoven, Andor F., et al.
Publicado: (2016)

Accuracy of SPECT/CT‐based lung dose calculation for Holmium‐166 hepatic radioembolization before OSEM convergence
por: van Nierop, Bastiaan J., et al.
Publicado: (2018)

Radioembolisation in Europe: A Survey Amongst CIRSE Members
por: Reinders, Margot T. M., et al.
Publicado: (2018)

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel
por: Samim, Morsal, et al.
Publicado: (2017)

Quantitative dual-energy CT material decomposition of holmium microspheres: local concentration determination evaluated in phantoms and a rabbit tumor model
por: Gutjahr, Ralf, et al.
Publicado: (2020)

Clinical Results of Transarterial Radioembolization (TARE) with Holmium-166 Microspheres in the Multidisciplinary Oncologic Treatment of Patients with Primary and Secondary Liver Cancer
por: Drescher, Robert, et al.
Publicado: (2023)

The superior predictive value of (166)Ho-scout compared with (99m)Tc-macroaggregated albumin prior to (166)Ho-microspheres radioembolization in patients with liver metastases
por: Smits, Maarten L. J., et al.
Publicado: (2019)

Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series
por: Vermeulen, Sim, et al.
Publicado: (2023)

Study Protocol: Adjuvant Holmium-166 Radioembolization After Radiofrequency Ablation in Early-Stage Hepatocellular Carcinoma Patients—A Dose-Finding Study (HORA EST HCC Trial)
por: Hendriks, Pim, et al.
Publicado: (2022)

Radioembolization With Holmium-166 Polylactic Acid Microspheres: Distribution of Residual Activity in the Delivery Set and Outflow Dynamics During Planning and Treatment Procedures
por: Drescher, Robert, et al.
Publicado: (2021)

Use of an anti-reflux catheter to improve tumor targeting for holmium-166 radioembolization—a prospective, within-patient randomized study
por: van Roekel, Caren, et al.
Publicado: (2020)

Transarterial Radioembolization Planning and Treatment with Microspheres Containing Holmium-166: Determination of Renal and Intestinal Radionuclide Elimination, Effective Half-Life, and Regulatory Aspects
por: Kühnel, Christian, et al.
Publicado: (2022)

Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013)

Correction: Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013)

Therapeutic Effects of Holmium-166 Chitosan Complex in Rat Brain Tumor Model
por: Huh, Ryoong, et al.
Publicado: (2005)

Radiosensitivity of colorectal cancer to (90)Y and the radiobiological implications for radioembolisation therapy
por: Lee, Boon Q, et al.
Publicado: (2019)

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy
por: Ebbers, Sander C., et al.
Publicado: (2022)

Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol
por: van den Hoven, Andor F., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qkvp8te0l1fhhrsbmp9hp0a0jj